KRRO

Korro Bio (KRRO)

About Korro Bio (KRRO)

Korro Bio, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of a new class of genetic medicines based on editing RNA. The company was founded by Nessan Bermingham, Jean-Francois B. Formela, Joshua Rosenthal, and Andrew Fraley in 2018 and is headquartered in Cambridge, MA.

Details

Daily high
$8.47
Daily low
$7.80
Price at open
--
52 Week High
$55.89
52 Week Low
$5.20
Market cap
77.4M
Dividend yield
0.00%
Volume
91
Avg. volume
455,165
P/E ratio
-.87

Korro Bio News

Details

Daily high
$8.47
Daily low
$7.80
Price at open
--
52 Week High
$55.89
52 Week Low
$5.20
Market cap
77.4M
Dividend yield
0.00%
Volume
91
Avg. volume
455,165
P/E ratio
-.87